The National Institute for Clinical Excellence (NICE) is currently reviewing the clinical and economic evidence on the use of four drugs used in the treatment of Alzheimer’s disease – donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa). In Scotland, NHS Quality Improvement Scotland...